Pharmaceutical Manufacturing – Benzonatate Capsules
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract involves the pharmaceutical manufacturing of 100 mg benzonatate capsules for the Department of Defense, specifically through the Medical Supply Chain Pharm FSA. The contractor is required to produce the medication in 100-count bottles that strictly adhere to FDA compliance, USP standards, and DLA technical requirements. The opportunity was posted on August 17, 2026, with a response deadline of August 24, 2026. Classified under NAICS code 325412, this procurement focuses on the production of pharmaceutical preparations to meet specific military medical supply chain needs.
General Info
Agency
NAICS
Place of Performance
USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-4668.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
BENZONATATE CAPSULES
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
